Acute myocardial infarction

Area of Science:

• Cardiology
• Internal Medicine
• Public Health

Background:

• Acute myocardial infarction (AMI) is a primary cause of global morbidity and mortality.
• Despite improvements, AMI remains a significant health challenge worldwide.
• Traditional classification into ST-elevation MI and non-ST-elevation MI may be simplified for management.

Purpose of the Study:

• To review the pathophysiology, epidemiology, and modern management of AMI.
• To highlight recent advances in reperfusion strategies and pharmacological treatments for AMI.
• To emphasize a unified approach to AMI management.

Main Methods:

• Review of current literature on AMI pathophysiology and epidemiology.
• Analysis of trends in risk stratification and invasive strategies.
• Evaluation of advancements in antiplatelet agents, anticoagulants, and statin therapy.
• Discussion of contemporary reperfusion techniques, including percutaneous coronary intervention and fibrinolysis.

Main Results:

• Significant progress in AMI prognosis over the last decade.
• Increased utilization of invasive strategies and rapid revascularization.
• Enhanced efficacy of antiplatelet and anticoagulant therapies.
• Greater adoption of secondary prevention measures like statins.

Conclusions:

• A simplified, unified management approach for AMI is feasible and beneficial.
• Continued advancements in reperfusion and pharmacotherapy are crucial for improving AMI outcomes.
• Effective secondary prevention strategies remain essential in reducing long-term morbidity and mortality.